Literature DB >> 27039715

Preventive and Risk Reduction Strategies for Women at High Risk of Developing Breast Cancer: a Review.

Arvind Krishnamurthy1, Viveka Soundara, Vijayalakshmi Ramshankar.   

Abstract

Breast cancer is the most commonly diagnosed invasive cancer among women. Many factors, both genetic and non-genetic, determine a woman's risk of developing breast cancer and several breast cancer risk prediction models have been proposed. It is vitally important to risk stratify patients as there are now effective preventive strategies available. All women need to be counseled regarding healthy lifestyle recommendations to decrease breast cancer risk. As such, management of these women requires healthcare professionals to be familiar with additional risk factors so that timely recommendations can be made on surveillance/risk-reducing strategies. Breast cancer risk reduction strategies can be better understood by encouraging the women at risk to participate in clinical trials to test new strategies for decreasing the risk. This article reviews the advances in the identification of women at high risk of developing breast cancer and also reviews the strategies available for breast cancer prevention.

Entities:  

Mesh:

Year:  2016        PMID: 27039715     DOI: 10.7314/apjcp.2016.17.3.895

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  4 in total

Review 1.  Risk Reduction Strategies in Breast Cancer Prevention.

Authors:  Mauricio Costa; Paula Saldanha
Journal:  Eur J Breast Health       Date:  2017-07-01

2.  Apps for individuals diagnosed with breast cancer: a preliminary assessment of the content and quality of commercially available apps in Spanish.

Authors:  Rubén Martín-Payo; Llara Ferreras-Losilla; Xana González-Méndez; Claudia Leirós-Díaz; Andrea Martínez-Urquijo; Maria Del Mar Fernández-Álvarez
Journal:  Mhealth       Date:  2021-01-20

3.  The role of health policy in the burden of breast cancer in Brazil.

Authors:  Francisco Winter Dos Santos Figueiredo; Tábata Cristina do Carmo Almeida; Débora Terra Cardial; Érika da Silva Maciel; Fernando Luiz Affonso Fonseca; Fernando Adami
Journal:  BMC Womens Health       Date:  2017-11-28       Impact factor: 2.809

4.  Network-pharmacology-based validation of TAMS/CXCL-1 as key mediator of XIAOPI formula preventing breast cancer development and metastasis.

Authors:  Neng Wang; Yifeng Zheng; Jiangyong Gu; Youli Cai; Shengqi Wang; Fengxue Zhang; Jianping Chen; Honglin Situ; Yi Lin; Zhiyu Wang
Journal:  Sci Rep       Date:  2017-11-06       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.